Skip directly to content

Physician Education: Pulmonology

Findings Link Sleep Apnea to Cardiovascular Disease

At UPMC, pulmonologists are conducting a number of unique investigations that corroborate theories that heavy snoring and sleep apnea are contributors to cardiovascular disease.

Using Phenotypes to Evaluate and Manage Asthma

Physician researchers at the University of Pittsburgh Asthma Institute at UPMC are now using molecular and genetic information to identify asthma phenotypes  and customize therapies in order to improve patient outcomes.

Acute Lung Injury and Pneumonia

Acute lung injury is a severe disease, affecting over 200,000 people annually. With a mortality rate of 40 to 50 percent, supportive care is the only option for many of these patients. Dr. Rama Mallampalli and his team at UPMC are conducting research that may lead to the development of new, non-antibiotic therapies for pneumonia and sepsis. By identifying the causes of pneumonia and other acute lung injuries, doctors at UPMC are devising novel treatments that are improving the quality of life for many patients.

NEJM Study Indicates Bronchial Valves Are Viable Option For Lung Volume Reduction

Some patients with chronic emphysema or COPD may soon have a minimally invasive option to help make breathing easier. Physician researchers from UPMC, a long-time leader in lung volume reduction surgery, recently published an article in the New England Journal of Medicine that reviewed the use of the VENT valve for bronchoscopic lung reduction surgery. In the study, the bronchial valve showed promise as a viable option for lung volume reduction surgery, improving lung function and walking distance.

Managing Pulmonary Hypertension in Sickle Cell Patients

Patients with sickle cell disease are living longer, and with this longevity, comes an increased risk for developing pulmonary hypertension. Mark Gladwin, MD, chief, Pulmonary, Allergy, and Critical Care Medicine, UPMC says it's important to screen sickle cell patients early for pulmonary hypertension and should a diagnosis be made, these patients need to be followed closely by pulmonary hypertension experts and hematologists.

A New Model for Treating Pulmonary Hypertension

Idiopathic pulmonary arterial hypertension (IPAH) is a challenging disease to treat. For this reason, patients diagnosed with pulmonary hypertension often find themselves bounced between cardiologists and pulmonologists. At UPMC's Comprehensive Pulmonary Hypertension Program, one of the largest in the country, patients are seen by these specialists at the same time, helping them receive an accurate diagnose faster and treatment quicker.